Quantcast
Last updated on April 20, 2014 at 5:20 EDT

Latest Metabolomics Stories

2011-08-12 12:01:15

Significant differences in metabolites between men and women lead researchers to propose gender-specific treatment for some diseases Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women. In a study to be published on August 11 in the open-access journal PLoS Genetics, scientists at the Helmholtz Zentrum Mnchen have concluded that there is a need for gender-specific therapies. Gender-specific therapies may be required for...

2011-08-02 19:46:58

The new Alkek Center for Molecular Discovery builds on and expands Baylor College of Medicine's established program in proteomics and adds a new developmental program in metabolomics (which refers to the metabolism in a cell and the products of that activity called metabolites) to advance studies of obesity, diabetes, heart disease and cancer. Directed by Dr. Bert O'Malley, chair of molecular and cellular biology at BCM and a National Medal of Science winner, and co-directed by Dr. Adam...

2011-07-25 17:23:00

MAHWAH, N.J., July 25, 2011 /PRNewswire/ -- Heartland Bridge Capital (OTCBB:HLBC) announced that it has signed a term sheet to make an investment in HepatoChem Inc. HepatoChem, headquartered in Cambridge, MA, offers pharmaceutical and biotech companies reliable and efficient access to small molecule metabolites. HepatoChem's innovative technology uses biomimetic catalysts to mimic the metabolic function of the liver. This unique technology, developed in collaboration with Professor John...

2011-07-25 08:00:00

ATLANTA, July 25, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today unveiled new technology solutions for increasing clinical laboratory efficiencies including the first CE Marked LC/MS/MS integrated solution for the quantification of everolimus (Certican®). (Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO ) Being displayed in Waters booth #3136 are these exciting new products. MassTrak(TM) Online Solid Phase Extraction Analyzer providing...

2011-07-18 07:00:00

EMERYVILLE, Calif., July 18, 2011 /PRNewswire/ -- Bionovo, Inc. (NASDAQ: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the publication of a study of the metabolic effects of its drug candidate, Bezielle, on cancer cells in the International Journal of Cancer. "This study confirms and expands our earlier understanding of the mechanism of Bezielle cell killing effect," said Uwe...

2011-07-07 13:00:00

MILFORD, Mass., July 7, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today welcomed the metabolomics program at Georgetown University Medical Center (GUMC) into its Centers of Innovation Program and recognized Albert J. Fornace Jr., MD, and Amrita Cheema, PhD, the directors of this pioneering program at Georgetown Lombardi Comprehensive Cancer Center, part of GUMC, in Washington, DC. (Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO ) In a ceremony at Georgetown...

2011-06-20 13:04:19

Researchers at Fred Hutchinson Cancer Research Center have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans. The findings, by principal investigator Amanda Paulovich, M.D., Ph.D., an associate member of the Hutchinson Center's Clinical Research Division, are published in Nature Biotechnology. Paulovich and colleagues demonstrated that a staged, targeted...

2011-06-07 00:00:31

New version advances measurement of targeted proteomics and metabolomics Denver, Colorado (PRWEB) June 06, 2011 Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Genedata Expressionist 7.0 for Mass Spectrometry at the 59th ASMS Conference on Mass Spectrometry. A complete, enterprise-level solution for managing and analyzing massive amounts of mass spectrometry (MS) data, Genedata Expressionist 7.0 advances quantitative...

2011-06-06 07:30:00

DENVER, June 6, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced its new Xevo® TQD tandem quadrupole mass detector, bringing the Waters® design philosophy of Engineered Simplicity(TM) to routine quantitative LC/MS/MS analysis. The newest addition to the Waters Xevo family of tandem quadrupole mass spectrometers, the Xevo TQD features the universal ion source architecture present on advanced mass spectrometers such as the Xevo TQ-S...

2011-06-06 07:30:00

DENVER, June 6, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced the SYNAPT® G2-S High Definition Mass Spectrometer, representing a significant step forward in performance for High Definition Mass Spectrometry. The SYNAPT G2-S incorporates both high-sensitivity Waters StepWave(TM) ion transfer optics and Triwave® ion mobility technologies along with a suite of new informatics tools to take qualitative and quantitative high resolution...